Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.12 TRY | +4.85% | +5.67% | +16.98% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Electric Utilities
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.98% | 296M | C | ||
+8.66% | 1.89B | - | ||
-2.94% | 755M | B- | ||
-56.57% | 534M | - | ||
-8.50% | 379M | - | C+ | |
+17.50% | 74.45M | - | - | |
-6.24% | 58.44M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BIOEN Stock
- Ratings Biotrend Cevre ve Enerji Yatirimlari